Reuters logo
BRIEF-Redhill Biopharma provides 2017 year-end business update
December 5, 2017 / 2:38 PM / 9 days ago

BRIEF-Redhill Biopharma provides 2017 year-end business update

Dec 5 (Reuters) - Redhill Biopharma Ltd:

* REDHILL BIOPHARMA PROVIDES 2017 YEAR-END BUSINESS UPDATE

* REDHILL BIOPHARMA LTD - ‍COST REDUCTION PLAN IS IN PLACE TO GRADUALLY REDUCE AVERAGE QUARTERLY CASH BURN RATE IN 2018 TO APPROXIMATELY $8.5 MILLION​

* REDHILL BIOPHARMA LTD - FOCUSING ON DELIVERING PHASE III DATA READ-OUTS WITH RHB-104 FOR CROHN‘S DISEASE AND TALICIA FOR H. PYLORI INFECTION Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below